Generex Biotechnology Corporation announced earnings results for the first quarter ended October 31, 2020. For the first quarter, the company announced sales was USD 88,435 compared to USD 721,661 a year ago. Operating loss was USD 14.113 million compared to USD 4.548 million a year ago. Net loss was USD 10.730 million compared to USD 9.125 million a year ago. Basic loss per share from continuing operations was USD 0.11 compared to USD 0.13 a year ago.